>
Biosensors International logo

B20 - Biosensors International Share Price

S$0.83 0.0  0.0%

Last Trade - 04/04/16

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £191.3m
Position in Universe th / 6090
Bullish
Bearish
Unlock B20 Revenue
Momentum
Relative Strength (%)
1m -3.76%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2010 2011 2012 2013 2014 2015 2016E 2017E CAGR / Avg
116.2 156.6 292.1 336.2 323.8 308.4 +21.6%
+379.1 +41.2 +466.1 -72.1 -64.0
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 31 December 2015,Biosensors International Group Ltd revenues decreased 18%to $190.7M. Net income decreased 45% to $12.3M. Revenuesreflect Interventional Cardiology segment decrease of 16%to $155.9M, Licensing Revenue segment decrease of 48% to$11.3M. Net income also reflects restructuring ofoperations increase from $2M to $4.2M (expense), Foreignexchange gain/(loss).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

B20 Revenue Unlock B20 Revenue

Net Income

B20 Net Income Unlock B20 Revenue

Normalised EPS

B20 Normalised EPS Unlock B20 Revenue

PE Ratio Range

B20 PE Ratio Range Unlock B20 Revenue

Dividend Yield Range

B20 Dividend Yield Range Unlock B20 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
B20 EPS Forecasts Unlock B20 Revenue
Profile Summary

Biosensors International Group, Ltd. develops, manufactures and markets medical devices for interventional cardiology and critical care procedures. The Company's segments include Critical care, Interventional cardiology, Cardiac diagnostic, and Licensing and royalties revenue. It offers devices and solutions in therapeutic area, including cardiovascular, endovascular, critical care and cardiac imaging. In the cardiovascular area, the Company focuses on drug-eluting stents, drug coated stents and bare metal stents, as well as angioplasty catheters for the treatment of coronary artery disease. Its endovascular product portfolio includes stenting and ballooning solutions for superficial femoral artery, and below the knee interventions. Its critical care products include vascular catheters, pressure monitoring kits and blood pressure transducers. It offers D-SPECT, a nuclear cardiac imaging system. Its products include BioFreedom, BioMatrix Flex, Axxess, Chroma, Gazelle and BioStream.

Directors
Last Annual March 31st, 2015
Last Interim December 31st, 2015
Incorporated May 28, 1998
Public Since May 20, 2005
No. of Shareholders: 6,906
No. of Employees: 254
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange Singapore Exchange Securities Trading Ltd
Shares in Issue 1,700,487,443
Free Float (0.0%)
Eligible for
ISAs
SIPPs
B20 Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for B20
Upcoming Events for B20
Frequently Asked Questions for Biosensors International
What is the Biosensors International share price?

As of 04/04/16, shares in Biosensors International are trading at S$0.83, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the Biosensors International share price performed this year?

Shares in Biosensors International are currently trading at S$0.83 and the price has moved by 7.79% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Biosensors International price has moved by -34.25% over the past year.

What are the analyst and broker recommendations for Biosensors International?

There are no analysts currently covering Biosensors International.

When will Biosensors International next release its financial results?

Biosensors International is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2016-12-31
What is the Biosensors International dividend yield?

Biosensors International does not currently pay a dividend.

Does Biosensors International pay a dividend?

Biosensors International does not currently pay a dividend.

When does Biosensors International next pay dividends?

Biosensors International does not currently pay a dividend.

How do I buy Biosensors International shares?

To buy shares in Biosensors International you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Biosensors International?

Shares in Biosensors International are currently trading at S$0.83, giving the company a market capitalisation of £n/a.

Where are Biosensors International shares listed? Where are Biosensors International shares listed?

Here are the trading details for Biosensors International:

Country of listing: Singapore
Exchange: SES
Ticker Symbol: B20
What kind of share is Biosensors International?

We were not able to load our ranking data for Biosensors International

Is there a Biosensors International share price forecast 2021?

We were not able to load any forecast data for Biosensors International.

How can I tell whether the Biosensors International share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Biosensors International. Over the past six months, the relative strength of its shares against the market has been -5.5%. At the current price of S$0.83, shares in Biosensors International are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Biosensors International PE Ratio?

We were not able to find PE ratio data for Biosensors International.

Who are the key directors of Biosensors International?

We were unable to find the directors for Biosensors International.

Who are the major shareholders of Biosensors International?

Here are the top five shareholders of Biosensors International based on the size of their shareholding:

Similar to B20
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.